Where Healing Becomes Enhancement

Part 16 of 30 · Series date: July 5, 2026

A person loses an ability and seeks to regain it. The ethical purpose seems clear. But suppose the device that helps also provides an ability the person never possessed. A prosthesis might include a useful feature beyond ordinary function. Has care become something morally different at the moment it exceeds an average?

Separating healing from enhancement helps the debate. The label alone cannot settle it. Normal ability varies. Prevention changes what may harm us later. A device can both restore an ability and add a new one.

Why the distinction matters

The goal of healing can give us a clearer reason to act. An invasive procedure that addresses a serious limitation may offer a large benefit. Performing the same procedure on a healthy person for a minor advantage may not justify comparable risks. The purpose changes the benefit side of the review.

The distinction also helps institutions allocate resources. A society may rightly fund basic care before optional gains in performance. That choice does not require calling every enhancement wrong. It concerns competing needs and limited means.

The President's Council on Bioethics studied performance, longer life, and happiness. It also explored why healing and enhancement can be hard to separate. Its report provides a major cautionary view rather than an undisputed final answer. Beyond Therapy.

Why the distinction breaks down

The defender of enhancement asks why average ability should be a moral ceiling. Education builds abilities on purpose. Preventive measures can make us less vulnerable than we would otherwise be. A safe, optional feature may help someone join in. Being above average is a weak reason, by itself, to ban it.

There is also no single uncomplicated baseline. What should care aim for: a person's earlier ability, an average, or what they need for a goal? Someone born without an ability cannot regain a skill they once had. They may still have strong reasons to seek help.

The critic can reply that education and invasive modification differ in risk, reversibility, and effects on others. That reply is important. Those features give us clearer grounds to judge than the label alone.

The question behind the label

Imagine a device with two settings. One helps with an ordinary task. The other adds a new ability. The extra setting might add little risk. Or it might create serious problems for privacy or safety. Its ethical status depends on the actual difference, not just on being called an upgrade.

Ask what the person wants and what evidence supports it. What other choices exist? What are the risks? Who controls the change? A therapeutic claim should not excuse bad evidence. An enhancement label should not automatically defeat a reasonable benefit.

Consent matters, but the surrounding conditions matter too. Someone pressured by employment requirements may face a different decision from a person choosing freely. Public funding raises a different question from private choice. A person may have good reason to seek a treatment. That does not mean it should receive public funds ahead of urgent care.

Four baselines, four different judgments

Suppose a device increases a person's ability to hear. Compared with their earlier ability, it may restore a loss. Compared with the population average, it may remain below ordinary hearing. Compared with the demands of a particular job, it may provide an advantage. Compared with the person's own goals, it may simply make conversation with a grandchild easier. The same intervention can look different because the baseline changes.

This is why a definition of enhancement should identify its reference point. “Beyond normal” sounds clear. But normal for whom, at what age, in which setting, and for what goal? A measured average describes a distribution; it does not automatically establish a moral ceiling. A previous personal state can guide restoration, but it cannot explain all assistance for congenital conditions. A social standard can help people join in. It can also contain barriers that we could remove.

The therapeutic distinction still has force. A greater expected benefit can justify burdens that would be excessive for a minor competitive edge. Public resources may properly prioritize serious need. These judgments depend on real benefits and burdens. A preferred label is not enough.

Permission, access, and public priority

Three questions are often collapsed. Should an adult be permitted to seek an intervention? Should it be made practically accessible? Should public resources prioritize it over other needs? An affirmative answer to the first does not automatically settle the others. A society can allow an optional benefit while paying for basic care first. It can also recognize a serious need before a safe way to meet it exists.

The distinction matters for both sides. Supporters cannot conclude a public duty to fund every enhancement from the value of bodily choice. Ranking below urgent care in a budget does not, by itself, mean a treatment should be banned. Good policy needs separate reasons for restrictions, provision, and priority.

Now picture a device that restores an ability. It also has a cheap extra feature that adds little risk. Requiring the recipient to disable the feature only to remain within an average may be arbitrary. But a cheap feature may record others or give a provider remote control. Its price does not settle those concerns. What appears to be one product can contain several ethically different functions.

A ladder does not dictate its last rung

The slippery-slope argument has a serious form and a weak form. The weak claim says that accepting one change commits us to every larger change. That does not follow. We can distinguish uses by risk, consent, effects on others, and purpose. Accepting a prosthetic joint does not commit someone to forced changes to the mind.

The serious concern is about what people will do. Will they keep those limits when money, competition, and public hopes push toward more uses? A boundary can be logically defensible yet socially difficult to preserve. That is a reason to design protections, review standards, and rights of refusal early. It is not proof that all beginnings must be forbidden.

The question “Where does healing end?” therefore opens several inquiries. What baseline is being used? What benefit is sought? Who bears the risk? Which institution is deciding? What happens to those who remain outside the new norm? Answering them produces a stronger boundary than pretending a single word can settle every case.

A person is not a design

Do not imply that an unchanged body is defective. Do not imply that a changed body is less real. Both positions turn a preferred form into a standard of worth. The goal is to serve an already valuable person, not manufacture value through performance.

The therapy–enhancement distinction is therefore a useful opening question. It helps us ask about the goal and how strong a reason we need. It does not finish the review. Look closely at the benefits, risks, freedom, and conditions of the choice.